pregnancy Archives
Study to explore nasal bacteria of children born by C-section
Nov. 10, 2022—Vanderbilt is recruiting pregnant women scheduled to undergo a repeat cesarean section at VUMC for a study of potential interventions to change the bacteria living in the nose of children born by C-section.
Targeted cancer drug during pregnancy
Aug. 2, 2022—The targeted cancer therapy alectinib was safe as a treatment for lung cancer during two pregnancies in a patient with non-small cell lung cancer, according to a case report from Vanderbilt physicians.
Study shows two vaccine doses for mothers eases COVID complications for infants
Jul. 6, 2022—Infants younger than 6 months were better protected from COVID-19 complications when mothers received two doses of the vaccine while pregnant, according to Vanderbilt researchers.
Rheumatoid arthritis: special deliveries
Mar. 28, 2022—Birth outcomes including postpartum infection and blood transfusion were similar in women with and without rheumatoid arthritis, and continued use of disease-modifying antirheumatic drugs and biologics is recommended to limit steroid exposure.
Invasive strep can defy zinc toxicity
Feb. 28, 2022—Vanderbilt researchers find that invasive Group B Streptococcus strains, a significant risk to pregnant patients and infants, can grow in presence of toxic zinc levels.
Common questions about COVID vaccine and pregnancy
Nov. 15, 2021— Recently, Vanderbilt University Medical Center’s Chief Epidemiologist, Dr. Tom Talbot, sat down to speak with his colleague Dr. Milner Staub, one of VUMC’s Adult Infectious Diseases specialists, about COVID vaccines, pregnancy and fertility. Staub, who is pregnant and has been vaccinated for COVID, answered important questions about issues and misperceptions associated with pregnancy and...
HCV infection among pregnant people increasing
Oct. 29, 2021— by Emily Stembridge Hepatitis C virus (HCV) infection can lead to long-term health problems including liver damage, liver failure, cirrhosis, liver cancer and even death. These outcomes are especially dangerous for pregnant people and their babies. The leading cause of HCV in the U.S. is injection drug use as a result of opioid use...
Fibroids and preterm birth
Sep. 30, 2021—In a large, prospective study, Vanderbilt researchers found no association between fibroids and any clinical subtype of preterm birth, supporting a reconsideration of the impression that fibroids increase preterm birth risk.
Alarming number of pregnant COVID-19 patients hospitalized in August
Sep. 1, 2021—Vanderbilt University Hospital treated 39 pregnant patients hospitalized with active COVID-19 infections in August, 10 of whom were admitted to the intensive care unit (ICU).
VUMC sees increase of COVID-19 in pregnant patients
Aug. 2, 2021—Physicians at Vanderbilt University Medical Center (VUMC) have recently noticed an increase in pregnant patients ill with COVID-19. These cases are especially concerning due an increased risk of hospitalization, ICU admission, need for mechanical ventilation and ventilatory support, and increased risk of death in pregnant patients with COVID-19 compared to non-pregnant patients.
Fibroids and birth outcomes
Sep. 8, 2020—Women with three or more uterine fibroids — non-cancerous growths — during pregnancy are more likely to have infants with reduced birthweight and may need additional surveillance.
Study finds patients’ access to opioid treatment cumbersome
Aug. 14, 2020—Women are having a difficult time getting into treatment for opioid addictions, according to a Vanderbilt University Medical Center study published today in JAMA Open.
